CIK: 0001969764 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value ($000): $82,392 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PAGP | PLAINS GP HOLDINGS LP-CL | 1,272,360 | $24,722 | 30.0% | $18.82 | — | COMM | 72651A207 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 6,153,091 | $13,906 | 16.9% | $3.48 | -18.2% | COMM | 004468500 |
| — | AKERO THERAPEUTICS INC | 228,884 | $12,213 | 14.8% | $24.86 | — | COMM | 00973Y108 |
| PHAT | PHATHOM PHARMACEUTICALS I | 922,927 | $8,851 | 10.7% | $8.64 | -36.0% | COMM | 71722W107 |
| ABEO | ABEONA THERAPEUTICS INC | 974,022 | $5,532 | 6.7% | $5.31 | +7.1% | COMM | 00289Y206 |
| — | APPLIED THERAPEUTICS INC | 11,285,420 | $3,511 | 4.3% | $2.53 | — | COMM | 03828A101 |
| MIST | MILESTONE PHARMACEUTICALS | 1,791,557 | $3,476 | 4.2% | $1.86 | -28.5% | COMM | 59935V107 |
| DCTH | DELCATH SYSTEMS INC | 226,052 | $3,074 | 3.7% | $13.87 | +0.6% | COMM | 24661P807 |
| TCRX | TSCAN THERAPEUTICS INC | 2,087,139 | $3,026 | 3.7% | $4.58 | -68.4% | COMM | 89854M101 |
| ZVRA | ZEVRA THERAPEUTICS INC | 231,874 | $2,043 | 2.5% | $7.08 | +14.6% | COMM | 488445206 |
| CAPR | CAPRICOR THERAPEUTICS INC | 70,000 | $695 | 0.8% | $10.56 | 0.0% | COMM | 14070B309 |
| MATPF | MAAT PHARMA SACA | 94,181 | $452 | 0.5% | $6.26 | — | COMM | F5888J116 |
| — | ATHIRA PHARMA INC | 1,492,792 | $451 | 0.5% | $2.43 | — | COMM | 04746L104 |
| — | EIGER BIOPHARMACEUTICALS | 146,381 | $423 | 0.5% | $5.00 | — | COMM | 28249U204 |
| — | WTS - Achieve Life Sci | 3,699,999 | $14 | 0.0% | $0.00 | — | COMM | 004468187 |
| — | CHINOOK THERAPEUTICS | 79,357 | $3 | 0.0% | — | — | COMM | 169CVR016 |